Abstract
Treatment of septic shock has become standardized nationwide. Patients who fail adequate fluid resuscitation require urgent treatment with vasopressors. Only recently has physician's choice of vasopressor expanded to incorporate synthetic Angiotensin II (SA2). A 33-year-old male was transferred for
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
